| Dr Darci Marie Schwendemann, PHARMD | |
|
9106 S Sheridan Rd, Tulsa, OK 74133-5332 | |
| (918) 492-3735 | |
| Not Available |
| Full Name | Dr Darci Marie Schwendemann |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 9106 S Sheridan Rd, Tulsa, Oklahoma |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003184359 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 13126 (Oklahoma) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Darci Marie Schwendemann, PHARMD 9106 S Sheridan Rd, Tulsa, OK 74133-5332 Ph: (918) 492-3735 | Dr Darci Marie Schwendemann, PHARMD 9106 S Sheridan Rd, Tulsa, OK 74133-5332 Ph: (918) 492-3735 |
News Archive
Theravance, Inc. announced today that it has earned a milestone payment of $20 million for the U.S. Food and Drug Administration (FDA) approval of VIBATIV (telavancin) and supplying its collaboration partner, Astellas Pharma US, Inc. (Astellas), with the launch inventory for the first commercial sale in the United States.
New estimates indicate that over 650 000 children develop tuberculosis (TB) every year in the 22 countries with a high burden of the disease (HBCs)*—almost 25% higher than the total number of new cases worldwide estimated by WHO in 2012 (530 000)**. The research, published in The Lancet Global Health, also suggests that about 15 million children are exposed to TB every year, and roughly 53 million are living with latent TB infection, which can progress to infectious active TB at any time.
The National Eye Institute (NEI), part of NIH, is participating in the Inaugural Press Conference from the Association for Research in Vision and Ophthalmology Annual Meeting (ARVO 2016), the largest gathering of eye and vision researchers in the world, attracting over 11,000 attendees from more than 75 countries.
A review article published in the journal Frontiers in Physiology by researchers affiliated with the Federal University of São Paulo in Brazil discusses the mechanisms whereby SARS-CoV-2 damages the kidneys, potentially serving as a basis for further research in pursuit of treatments to prevent severe renal problems and even chronic kidney disease in COVID-19 patients.
Patients who complain of upper gastrointestinal (GI) symptoms often face a diagnosis of either gastroesophageal reflux disease (GERD) or functional dyspepsia. Because the two conditions often overlap, it can be difficult to distinguish between them and diagnose them properly. Yet ambulatory care facilities and hospitals have reported a dramatic increase in the number of GERD-related visits/discharges in recent years.
› Verified 2 days ago
Dr. Bradley Howard Brown, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6040 S Yale Ave, Tulsa, OK 74135 Phone: 918-494-4040 Fax: 918-496-4702 | |
Mrs. Laura Lorraine Thorpe, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3840 S 103rd East Ave, Tulsa, OK 74146 Phone: 918-660-0601 | |
Dr. Ted D Schwendemann, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11332 E 31st St, Tulsa, OK 74146 Phone: 918-622-9684 Fax: 918-622-6901 | |
Katie Deak, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2323 W Edison St, Tulsa, OK 74127 Phone: 918-582-1375 Fax: 918-560-9001 | |
Carter G Brashears, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1334 N Lansing Ave, Tulsa, OK 74106 Phone: 918-295-6131 | |
Mr. David Yin-lun Kwok, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10938 S Memorial Dr, Tulsa, OK 74133 Phone: 918-394-4075 Fax: 918-394-4095 |